Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly

Medical Principles and Practice

Volumn 18, Issue 3, 2009, Pages 228-232

  Baykan, Merih ^a   Erem, Cihangir ^a   Gedikli, Ömer ^a   Hacihasanoglu, Arif ^a   Erdogan, Turan ^a   Kocak, Mustafa ^a   Kaplan, Şahin ^a   Korkmaz, Levent ^a   Çelik, Şükrü ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Acromegaly; Brachial artery; Flow mediated dilatation

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; VASODILATATION;

ACROMEGALY; ADULT; AGED; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; DILATATION, PATHOLOGIC; FEMALE; HUMANS; LUMINESCENCE; MALE; MIDDLE AGED; RISK FACTORS; VASODILATION; YOUNG ADULT;

EID: 64349124038     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204355     Document Type: Article

References (25)

1. Colao A, Marzullo P, Di Somma C, Liombardi G: Growth hormone and the heart. Clin Endocrinol 2001; 54: 137-154.
2. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B: Epidemiology and long-term survival in acromegaly. Acta Med Scand 1988; 223: 327-335.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
4. Neunteufl T, Heher S, Katzenschlager R, Wölfl G, Kostner K, Maurer G, Weidinger F: Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-210.
5. Sowers JR: Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29: 691-699.
6. Tan KC, Shiu SW, Janus ED, Lan KS: LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth hormone-1. Atherosclerosis 1997; 129: 59-65.
7. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR: Insulin-like growth factor 1 diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996; 137: 1798-1803.
8. Brevetti G, Marzullo P, Silvestro A, Pivonell R, Oliva G, di Soma C, Lombardi G, Colao A: Early vascular alterations in acromegaly. J Clin Endocrinol Metab 2002; 87: 3174-3179.
9. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated dilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
10. Lie JT: Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980; 100: 41-52.
11. Chen Y, Capron L, Magnusson JO, Wallby LA, Arnquist HJ: Insulin-like growth factor-1 stimulation vascular smooth muscle cell proliferation in rat aorta in vivo. Growth Horm IGF Res 1998; 8: 299-303.
12. Bruel A, Oxlund H: Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart. Eur J Endocrinol 1995; 132: 195-199.
13. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE: Impairment of endothelium-dependent dilatation is an early event and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50-55.
14. Tribe RM, Poston L: Oxidative stress and lipid in diabetes: a role in endothelium vasodilator dysfunction. Vasc Med 1996; 1: 195-206.
15. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
16. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22(suppl 4):S1-S14.
17. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F: Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111-118.
18. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
19. Brevetti G, Martone VD, de Cristofaro T, Corrado S, Silvestro A, Di Donato AM, Bucur R, Scopacasa F: High levels of adhesion molecules are associated with impaired endothelium- dependent vasodilatation in patients with peripheral arterial disease. Thromb Haemost 2001; 85: 63-66.
20. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-1474.
21. Ferns GA, Motani AS, Anggard EE: The insulin- like growth factors: their putative role in atherogenesis. Artery 1991; 18: 197-225.
22. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F: Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004; 110: 2260-2265.
23. Li G, Del Rincon JP, Jahn LA, Wu Y, Gaylinn B, Thorner MO, Liu Z: Growth hormone exerts an acute vascular effects independent of systemic or muscle insulin-like growth factor- 1. Clin Endocrinol Metab 2008; 93: 1379-1385.
24. Corretti MC, Plotnick GD, Vogel RA: Smoking correlates with flow-mediated brachial artery vasoreactivity but not cold pressor activity in men with coronary artery disease. Int J Card Imaging 1998; 14: 11-17.
25. Anderson TJ, Elstein E, Haber H, Charbonneau F: Comparative study of ACE inhibition, angiotensin II, antagonism, and calcium channel blockade on flow-mediated vasodilatation in patients with coronary disease. J Am Coll Cardiol 2000; 35: 60-66.